EssilorLuxottica (OTCMKTS:ESLOY) Hits New 12-Month Low – What’s Next?

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $91.44 and last traded at $91.85, with a volume of 38013 shares changing hands. The stock had previously closed at $93.88.

Analysts Set New Price Targets

ESLOY has been the topic of several research analyst reports. The Goldman Sachs Group cut EssilorLuxottica from a “buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft started coverage on shares of EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating for the company. Finally, Zacks Research lowered shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Report on ESLOY

EssilorLuxottica Price Performance

The firm’s 50-day moving average price is $98.99 and its 200 day moving average price is $119.42. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Further Reading

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.